SCHEMBL739448

SCHEMBL739448

COCCCn1c(C2CCCN(C(=O)CC(N)CNC(=O)c3ccc(Cl)cc3)C2)nc2ccccc21

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 7/20 0.42
HRH1 P35367 5/20 0.42
CYP2D6 P10635 4/20 0.42
CHRM1 P11229 3/20 0.42
TP53 P04637 4/20 0.42
MAPT P10636 2/20 0.42
OPRM1 P35372 2/20 0.41
OPRD1 P41143 2/20 0.41
OPRK1 P41145 2/20 0.41
ITK Q08881 2/20 0.40
LMNA P02545 1/20 0.40
TSHR P16473 1/20 0.40
MAPK1 P28482 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HSD17B10 Q99714 1/20 0.40
KMT2A Q03164 2/20 0.40
HPGD P15428 1/20 0.40
MCHR1 Q99705 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL739446 1.00 KCNH2 (0.42) KCNH2HRH1CYP2D6CHRM1TP53
SCHEMBL739447 1.00 KCNH2 (0.42) KCNH2HRH1CYP2D6CHRM1TP53
SCHEMBL741888 0.94 OPRK1 (0.44) KCNH2HRH1CYP2D6CHRM1OPRK1
SCHEMBL741887 0.94 OPRK1 (0.44) KCNH2HRH1CYP2D6CHRM1OPRK1
SCHEMBL740677 0.94 KCNH2 (0.46) KCNH2HRH1CYP2D6CHRM1TP53
SCHEMBL740676 0.94 KCNH2 (0.46) KCNH2HRH1CYP2D6CHRM1TP53
SCHEMBL740675 0.94 KCNH2 (0.46) KCNH2HRH1CYP2D6CHRM1TP53
SCHEMBL738808 0.93 HRH1 (0.44) KCNH2HRH1CYP2D6CHRM1TP53
SCHEMBL739789 0.93 KCNH2 (0.47) KCNH2HRH1CYP2D6CHRM1TP53
SCHEMBL739790 0.93 KCNH2 (0.47) KCNH2HRH1CYP2D6CHRM1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138168-B1 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-20 US claimed
US-8138168-B1 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-20 US disclosed